Drug intelligence / Profile preview

dinoprostone gel

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Vaginal
01

Overview

0.5mg PGE2 gel is a specific formulation of dinoprostone (prostaglandin E2) gel, a small molecule prostaglandin analog used for cervical ripening and the induction of labor. The active ingredient, dinoprostone, is a naturally occurring prostaglandin that acts as an agonist on prostaglandin EP receptors (specifically EP1, EP2, EP3, and EP4) in the uterus and cervix. This action stimulates uterine contractions and promotes cervical softening and ripening by breaking down collagen. A well-known brand name for this formulation is Prepidil, which is administered endocervically. It is utilized in clinical settings, such as in trials evaluating early versus delayed induction of labor in patients presenting with prelabor rupture of membranes (PROM) at term.

Brand names
PrepidilProstin E2
Other names
0.5mg PGE2 geldinoprostone cervical geldinoprostone vaginal gelPGE2 gelPGE-2 gelPGE 2 gelprostaglandin E2 gel
02

Targets

PTGER1 (Prostaglandin E Receptor 1)PTGER2 (Prostaglandin E2 receptor EP2)PTGER3 (Prostaglandin E2 receptor EP3 subtype)PTGER4 (Prostaglandin E2 receptor EP4 subtype)

Beyond the preview

Go deeper on dinoprostone gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dinoprostone gel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call